Weight Loss Research, Health Insights & Smarter Choices
New study reveals lifelong use of weight-loss drugs like Mounjaro and Wegovy may be necessary A New Study Offers Clues About Why GLP-1 Weight Loss Varies Wegovy and Mounjaro have changed the way doctors approach obesity treatment. Yet one question remains common: why do some people lose much more weight than others on these medications? … Read more
FDA Approves New High-Dose of Wegovy HD 7.2 mg On March 19, 2026, the U.S. Food and Drug Administration approved Wegovy HD, a 7.2 mg once-weekly injectable dose of semaglutide, for certain adults with obesity or overweight plus at least one weight-related condition. The higher dose gives eligible patients another treatment option when clinically appropriate. … Read more
GLP-1 drugs in 2026: More people without diabetes use drugs for weight loss GLP-1 medicines have changed how doctors approach obesity, type 2 diabetes and several related health problems. Drugs such as Wegovy, Ozempic and other GLP-1-based treatments can reduce appetite, improve blood sugar control and help many people lose significant amounts of weight. But … Read more